OR WAIT 15 SECS
© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
December 02, 2020
As the world remains battling the coronavirus pandemic, there are still significant and unmet needs for those fighting chronic conditions and disorders like opioid use disorder (OUD).
November 29, 2020
FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.
November 23, 2020
Health plans build strategies to ensure their beneficiaries have easy access to and receive vital immunizations.
November 22, 2020
If Pfizer's vaccine gets an emergency use authorization, it could reach sites designated by states within a day.
November 17, 2020
Manufacturing issue creates setback for Alkermes on much-anticipated therapy that mitigates weight gain.
October 25, 2020
Gilead's Veklury gets full approval; AstraZeneca's Tagrisso heads toward second indication in NSCLC; another use for experimental antifungal therapy.
October 11, 2020
The PDUFA date for Alkermes' combination therapy is November 15, 2020.
September 29, 2020
Can data mined from EHRs match that from the gold standard, randomized clinical trials?
September 27, 2020
Approval for treatment of HES, update to address addictive nature of benzodiazepines.
September 20, 2020
Reports say Azar is asserting control over FDA as vaccine trials near completion, while Hahn is blocked from testifying on COVID-19.